Karthik Krishnan, Siti Khatijah Abdul Razak, Mohd Zulkifli Mustafa, Najib Majdi Yaacob, Zalina Zahari, Mohd Shahrulsalam Mohd Shah, Andee Dzulkarnaen Zakaria
{"title":"Kelulut Honey as an Alternate Source of Carbo-Loading in Abdominal Surgery Involving the Digestive System: A Randomised Blinded Comparative Study.","authors":"Karthik Krishnan, Siti Khatijah Abdul Razak, Mohd Zulkifli Mustafa, Najib Majdi Yaacob, Zalina Zahari, Mohd Shahrulsalam Mohd Shah, Andee Dzulkarnaen Zakaria","doi":"10.21315/mjms-06-2024-419","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Enhanced Recovery After Surgery (ERAS) is a multimodal perioperative care programme aimed at expediting recovery, reducing complications and minimising hospital stay by mitigating the metabolic stress response to surgery. One key shift in ERAS protocols is the replacement of traditional overnight fasting with carbohydrate-loading. Prolonged fasting increases insulin resistance, reduces cellular glucose uptake and glycogen formation, and may lead to hyperglycaemia. While maltodextrin is commonly used for carbohydrate-loading, it has a high glycaemic index and limited nutritional value. Kelulut Honey, a natural product rich in Trehalulose (a low-GI sugar), antioxidants, proteins, and vitamins may serve as a beneficial alternative.</p><p><strong>Methods: </strong>A randomised double-blind controlled trial involving 64 patients was conducted to evaluate the safety and efficacy of Kelulut Honey as a carbohydrate-loading agent in patients undergoing elective intra-abdominal surgery. Participants received either Kelulut Honey or commercial maltodextrin (Carborie<sup>®</sup>) according to ERAS protocol. Outcomes assessed included insulin resistance, residual gastric volume (RGV) and post-operative recovery parameters.</p><p><strong>Results: </strong>No significant difference was observed in blood glucose levels between the two groups. Average blood glucose at induction ranged from 5.3 to 5.6 mmol/L, with post-operative levels remaining below 10 mmol/L. Most participants passed flatus within 12 hours post-operatively, with over half ambulating and tolerating clear fluids within the same period. No significant differences were noted between groups in terms of complications, length of stay, pain control, or functional recovery. Intention-to-treat analysis confirmed comparable outcomes across all primary and secondary endpoints.</p><p><strong>Conclusion: </strong>Kelulut Honey is a safe and effective alternative to conventional carbohydrate drinks for pre-operative carbo-loading in abdominal surgery. It supports a modern shift away from the traditional surgical dogma of overnight fasting, with equivalent outcomes in glynaecmic control, RGV, and recovery compared to maltodextrin-based solutions.</p>","PeriodicalId":47388,"journal":{"name":"Malaysian Journal of Medical Sciences","volume":"32 2","pages":"50-63"},"PeriodicalIF":1.5000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12513527/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Malaysian Journal of Medical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21315/mjms-06-2024-419","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/30 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Enhanced Recovery After Surgery (ERAS) is a multimodal perioperative care programme aimed at expediting recovery, reducing complications and minimising hospital stay by mitigating the metabolic stress response to surgery. One key shift in ERAS protocols is the replacement of traditional overnight fasting with carbohydrate-loading. Prolonged fasting increases insulin resistance, reduces cellular glucose uptake and glycogen formation, and may lead to hyperglycaemia. While maltodextrin is commonly used for carbohydrate-loading, it has a high glycaemic index and limited nutritional value. Kelulut Honey, a natural product rich in Trehalulose (a low-GI sugar), antioxidants, proteins, and vitamins may serve as a beneficial alternative.
Methods: A randomised double-blind controlled trial involving 64 patients was conducted to evaluate the safety and efficacy of Kelulut Honey as a carbohydrate-loading agent in patients undergoing elective intra-abdominal surgery. Participants received either Kelulut Honey or commercial maltodextrin (Carborie®) according to ERAS protocol. Outcomes assessed included insulin resistance, residual gastric volume (RGV) and post-operative recovery parameters.
Results: No significant difference was observed in blood glucose levels between the two groups. Average blood glucose at induction ranged from 5.3 to 5.6 mmol/L, with post-operative levels remaining below 10 mmol/L. Most participants passed flatus within 12 hours post-operatively, with over half ambulating and tolerating clear fluids within the same period. No significant differences were noted between groups in terms of complications, length of stay, pain control, or functional recovery. Intention-to-treat analysis confirmed comparable outcomes across all primary and secondary endpoints.
Conclusion: Kelulut Honey is a safe and effective alternative to conventional carbohydrate drinks for pre-operative carbo-loading in abdominal surgery. It supports a modern shift away from the traditional surgical dogma of overnight fasting, with equivalent outcomes in glynaecmic control, RGV, and recovery compared to maltodextrin-based solutions.
期刊介绍:
The Malaysian Journal of Medical Sciences (MJMS) is a peer-reviewed, open-access, fully online journal that is published at least six times a year. The journal’s scope encompasses all aspects of medical sciences including biomedical, allied health, clinical and social sciences. We accept high quality papers from basic to translational research especially from low & middle income countries, as classified by the United Nations & World Bank (https://datahelpdesk.worldbank.org/knowledgebase/ articles/906519), with the aim that published research will benefit back the bottom billion population from these countries. Manuscripts submitted from developed or high income countries to MJMS must contain data and information that will benefit the socio-health and bio-medical sciences of these low and middle income countries. The MJMS editorial board consists of internationally regarded clinicians and scientists from low and middle income countries.